Synapse - Martin Tallman

Results (63)

De novo myelodysplastic syndromes in patients 20-50 years old characterized by frequent mutations in TP53 and transcription-related genes

Meeting Abstract

Epstein-Peterson, Z. D.; Spitzer, B.; McCarter, J.; McGovern, E.; Levine, R. L.; Tallman, M. S.
Blood (2019)

Fulltext@MSK | Save

Pegaspargase can safely be administered in adults age 40 and older with acute lymphoblastic leukemia

Meeting Abstract

Daley, R. J.; Rajeeve, S.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Lavery, J. A.; Tallman, M. S.; Geyer, M. B.; Park, J. H.
Blood (2019)

Fulltext@MSK | Save

Combined venetoclax and hypomethylating agent (HMA) therapy induces high response rates in patients with myelodysplastic syndrome including patients previously failing HMA

Meeting Abstract

Ball, B. J.; Famulare, C.; Stein, E. M.; Tallman, M. S.; Gill, S. I.; Manning, B. M.; Koprivnikar, J.; McCloskey, J.; Testi, R.; Al Ali, N.; more...
Blood (2019)

Fulltext@MSK | Save

Impact of pre-transplant measurable residual disease on relapse incidence and progression-free survival in older AML/MDS patients following allogeneic hematopoietic cell transplantation

Meeting Abstract

Lin, R. J.; Elko, T. A.; Devlin, S. M.; Perales, M. A.; Papadopoulos, E. B.; Castro-Malaspina, H.; Gyurkocza, B.; Shaffer, B. C.; Tamari, R.; Tallman, M.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Complex polyclonal resistance mechanisms to ivosidenib monotherapy in IDH1-mutant relapsed or refractory acute myeloid leukemia revealed by single cell sequencing analyses

Meeting Abstract

Wang, H.; Choe, S.; DiNardo, C. D.; Stein, E. M.; de Botton, S.; Fathi, A. T.; Tallman, M. S.; Kantarjian, H. M.; Stone, R. M.; Quek, L.; more...
Blood (2019)

Fulltext@MSK | Save

Superior survival with post-remission pediatric-inspired chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in adolescents and young adults with ph-negative acute lymphoblastic leukemia in first complete remission: Comparison of CALGB 10403 to patients reported to the CIBMTR

Meeting Abstract

Wieduwilt, M. J.; Stock, W.; Advani, A. S.; Luger, S. M.; Larson, R. A.; Tallman, M. S.; Appelbaum, F. R.; Zhang, M. J.; Bo-Subait, K.; Sandmaier, B. M.; more...
Blood (2019)

Fulltext@MSK | Save

Combined treatment with lenalidomide and epoetin alfa leads to durable responses in patients with epo-refractory, lower risk non-deletion 5q [del(5q)] MDS: Final results of the E2905 intergroup phase III study - An ECOG-ACRIN Cancer Research Group study, Grant CA180820, and the National Cancer Institute of the National Institutes of Health

Meeting Abstract

List, A. F.; Sun, Z.; Verma, A.; Bennett, J. M.; McGraw, K.; Maciejewski, J. P.; Komrokji, R. S.; Wassenaar, T. R.; Luger, S. M.; Mattison, R. J.; more...
Blood (2019)

Fulltext@MSK | Save

Maintenance decitabine (DAC) improves disease-free (DFS) and overall survival (OS) after intensive therapy for acute myeloid leukemia (AML) in older adults, particularly in FLT3-ITD-negative patients: ECOG-ACRIN (E-A) E2906 randomized study

Meeting Abstract

Foran, J. M.; Sun, Z.; Claxton, D. F.; Lazarus, H. M.; Arber, D. A.; Rowe, J. M.; Paietta, E.; Racevskis, J.; Altman, J. K.; Luger, S. M.; more...
Blood (2019)

Fulltext@MSK | Save

Molecular mechanisms mediating relapse following ivosidenib monotherapy in patients with IDH1-mutant relapsed or refractory acute myeloid leukemia